Does Dr. RAFAT ABONOUR have financial conflicts of interest?

Dr. RAFAT ABONOUR (MD) has received a total of $430,505 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $430,505 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RAFAT ABONOUR?

According to CMS Open Payments data, Dr. RAFAT ABONOUR received funding from JANSSEN BIOTECH ($253,019), GLAXOSMITHKLINE ($59,715), and E.R. SQUIBB & SONS, L.L.C ($30,499).

Does Dr. RAFAT ABONOUR receive research grants or speaking fees?

Dr. RAFAT ABONOUR has received $430,505 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RAFAT ABONOUR

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology

Practice Location: INDIANAPOLIS, IN 46202

NPI Number: 1750346755

LIFETIME INDUSTRY VALUE

$430,505

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABONOUR is a verified Internal Medicine, Hematology practitioner based in INDIANAPOLIS, IN.

Between 2021 and 2024, Dr. ABONOUR had an overall industry promotional and research financial footprint of $430,505 as recorded in the federal CMS Open Payments database.

$430,505 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABONOUR's primary funding source is JANSSEN BIOTECH, which accounts for $253,019 (representing 58.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN BIOTECH

Rank 1

$253,019

58.8%

GLAXOSMITHKLINE

Rank 2

$59,715

13.9%

E.R. SQUIBB & SONS, L.L.C

Rank 3

$30,499

7.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.